Documentation ephemerisx.com

Alzheimer's record overview

alzheimers.ephemerisx.com lists every FDA-approved Alzheimer's drug and traces the anti-amyloid antibody decisions in the FDA's own words.

Last updated September 29, 2026

Alzheimer's drugs · FDA record, at alzheimers.ephemerisx.com, is a reference to the FDA's record on Alzheimer's disease. It does two things:

  1. It lists every FDA-approved Alzheimer's drug: what its label says it is for, when it was first approved, whether it is still marketed, and its FDA applications.
  2. It covers the anti-amyloid antibodies in depth (Aduhelm, Leqembi, Kisunla and Leqembi Iqlik): every FDA decision, what each rested on, and where the agency held or moved its position across decisions.
The home page of alzheimers.ephemerisx.com on a desktop screen.
The home page on a desktop screen.

The header links, left to right:

LinkGoes to
DrugsThe table of every FDA-approved Alzheimer's drug, on the home page.
Anti-amyloidThe anti-amyloid antibody cards, on the home page.
TimelineThe decision timeline table, on the home page.
QuestionsThe threads page: five regulatory questions across every decision.
PendingThe Pending section on the home page.
MethodHow the record is built, and what it cannot show.

Between the site name and the links, a breadcrumb shows where you are: Threads, Method, About or a decision's title.

Pages#

PageAddressGuide
Home/The home page and, on desktop, the command center
Decision entries (7)/<decision>/Decision entries
Threads/threads/Regulatory questions
Method/method/How the record is built, the status legend, and What this record cannot show
About/about/Who publishes the record, and the privacy statement

Key ideas#

Decision
One FDA action on an anti-amyloid antibody: an approval or a complete response letter (a refusal).
Thread
One of five regulatory questions that recur across decisions, such as ARIA or Surrogate.
Position
The agency's own words on one thread in one decision, quoted and cited to its FDA page, and compared with an earlier position.
Status
How a position relates to the earlier one: Origin Consistent Conditional Departs Not addressed. See Status reference.

Every page ends with “Study, not advice.” and a reminder that quotes are verbatim from FDA documents and link to their source on fda.gov, and that the site is not affiliated with the FDA or any sponsor.